Lanham O'Dell & Company, Inc. Eli Lilly & CO Transaction History
Lanham O'Dell & Company, Inc.
- $167 Million
- Q1 2024
A detailed history of Lanham O'Dell & Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Lanham O'Dell & Company, Inc. holds 433 shares of LLY stock, worth $380,299. This represents 0.2% of its overall portfolio holdings.
Number of Shares
433
Previous 1,226
64.68%
Holding current value
$380,299
Previous $714,000
52.94%
% of portfolio
0.2%
Previous 0.5%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
3,755Shares Held
737MCall Options Held
7.09MPut Options Held
7.22M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$85.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$63.9 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$57.3 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$45.2 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$30.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $835B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...